The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sensium ISO Certification

24 Jan 2008 07:00

Embargoed Release: 07:00hrs Thursday 24 January 2008

Nanoscience Inc. (`The Group') Toumaz Technology Awarded ISO 13485 Medical Device Quality Management Certification for Sensium¢â€ž¢ Wireless Body Monitoring Platform Toumaz's commitment to the highest quality management standard required for medical device manufacture recognised by independent accrediting body

Nanoscience Inc, the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary Toumaz Technology Limited (`Toumaz') has received ISO 13485:2003 certification for its quality management system. ISO 13485 is the regulatory standard for the international medical industry and is closely related to ISO 9000. Toumaz (a leading provider of ultra-low power wireless infrastructure for body monitoring solutions) was assessed and certified as meeting the requirements of this strategically significant standard by independent body SGS, the world's leading verification and certification body.

ISO 13485 is a regulatory requirement in a number of international markets for the manufacture of medical devices, and forms the cornerstone for the CE certification of medical products in the EU. Meeting the ISO quality management standard is a crucial milestone in the ongoing commercialisation of Sensium¢â€ž¢, Toumaz's breakthrough ultra-low power wireless platform for the development of non-intrusive body monitors for healthcare and lifestyle markets. In November 2007, Toumaz took the top honours in the Electronics category of the prestigious Innovation in Engineering Awards - given by The Institution of Engineering and Technology - in recognition of the groundbreaking innovation of the Sensium as an enabling technology for highly valuable medical applications.

Keith Errey, COO, Toumaz, commented:

"We are delighted that Toumaz has been awarded the important ISO 13485 certification, which demonstrates our absolute commitment to quality throughout the product cycle including the manufacture of medical devices, and which will offer significant benefits to our customers."

The unique combination of ultra-low power wireless and signal processing in one small System-on-Chip (SOC) allows the economies of scale of the semiconductor industry to be harnessed to provide highly functional, robust, low cost, disposable and non-intrusive monitors for a wide range of healthcare applications.

The Sensium sensor interface and transceiver platform enables real-time, intelligent, ultra-low power wireless monitoring of multiple vital signs - such as ECG, heart rate, body temperature, respiration and physical activity (via a 3-axis accelerometer) - and is currently being developed in both disposable and non-disposable body monitoring products.

- Ends -

About Toumaz Technology (www.toumaz.com)

Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - the Sensium¢â€ž¢ - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx)¢â€ž¢ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Further information:Guy Spelman Nanoscience Inc. 07767 338 967 Andrew Tan Hansard Group 020 7245 1100 www.hansardgroup.co.uk Tim Goodman Ambrian Partners Limited 0207 776 6400 About Nanoscience Inc.:

Nanoscience is a specialist niche investor in emerging technologies with a strong commercial proposition from within the medical technology and semiconductor sectors.

NANOSCIENCE INC
Date   Source Headline
14th Oct 20197:30 amRNSSuspension - Frontier Smart Technologies Group
11th Oct 201910:42 amRNSResult of EGM and Suspension of Trading on AIM
8th Oct 20195:30 pmRNSFrontier Smart Technologies Group
3rd Oct 201910:00 amRNSClosure of Romania Operations
11th Sep 20199:30 amRNSBoard Appointments
9th Sep 20196:21 pmRNSRecommended Statutory Merger & AIM Cancellation
6th Sep 20193:20 pmRNSBlock Listing Update
5th Sep 201912:47 pmRNSHolding(s) in Company
3rd Sep 20194:39 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20198:54 amRNSAmendment to Standby Facility
2nd Sep 20195:23 pmRNSHolding(s) in Company
30th Aug 20192:21 pmRNSDirector/PDMR Dealing
30th Aug 20197:00 amRNSHalf-Year Results
29th Aug 20197:00 amRNSResponse to Science Group Statement
28th Aug 20194:23 pmRNSHolding(s) in Company
28th Aug 20198:47 amRNSFrontier Investment Update and Buy-Back
23rd Aug 201912:31 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
23rd Aug 201912:30 pmRNSConfirmation of Refinancing
21st Aug 20197:00 amRNSBoard Transition, Refinancing and Strategy
13th Aug 20197:00 amRNSBoard Change
7th Aug 201911:20 amRNSResponse to announcement by Frontier
7th Aug 20197:00 amRNSTrading & Discussion Update and EGM Requisition
31st Jul 20193:30 pmRNSExercise of Options and Total Voting Rights
30th Jul 20197:00 amRNSBoard Changes
22nd Jul 201910:09 amRNSHolding(s) in Company
22nd Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
19th Jul 20196:09 pmRNSExercise of Options and Total Voting Rights
19th Jul 20197:00 amRNSHolding(s) in Company
19th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
18th Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
17th Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
16th Jul 20197:00 amRNSHolding(s) in Company
16th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
15th Jul 20198:02 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSFurther Response to Science Group Offer
15th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
12th Jul 20194:07 pmRNSInvestment in Frontier Smart Technologies Group
12th Jul 20193:00 pmRNSFurther Response to Science Group Offer
12th Jul 20197:00 amRNSHolding(s) in Company
12th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSHolding(s) in Company
5th Jul 20197:00 amRNSFurther Response to Offer & update on discussions
2nd Jul 201912:20 pmRNSPublication of Offer Document
1st Jul 20199:01 amRNSResponse to Science Group Statement
1st Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
27th Jun 20194:10 pmRNSExercise of Options and Total Voting Rights
14th Jun 201911:40 amRNSInvestment in Frontier Smart Technologies Grp Ltd
14th Jun 20198:31 amRNSResponse to Science Group's announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.